Month: December 2018

Rare Disease Awareness

Commonalities of Rare Diseases

Collectively, rare diseases affect a huge number of people: about 25 million in the US and 400 million globally. To qualify as a rare disease per the US standard, fewer than 200,000 Americans must be affected by the condition, or per the EU standard, fewer than 1 in 2000 Europeans …

Read More »
Governing Body

New FDA Guidance for NASH Drug Development

Just in time for our final follow-up to the two previous articles on non-alcoholic steatohepatitis (NASH), the FDA released a new draft guidance for drugs being developed to treat the disease. In this blog, we present a couple of highlights from the guidance.   The new draft guidance very heavily …

Read More »
Office Building

Press Release: Biorasi Partners with RLH Equity to Spur Expansion and Growth

Florida-Based CRO seeks to expand offerings, global footprint, and headcount after successful investment transaction.   Biorasi, a leading full-service global contract research organization (CRO), is excited to announce that it has successfully closed an investment transaction with Riordan, Lewis & Haden | Equity Partners, a private equity firm based in …

Read More »
Pediatric Diabetes

The Future of Diabetes Treatment

Type 1 diabetes affects millions of people in the US alone. What’s worse is that the majority of patients do not achieve good control of their blood glucose levels. Management of type 1 diabetes has traditionally been cumbersome, time-consuming, and expensive, so better treatment methods are sorely needed.   For …

Read More »

Download a Sample Rescue Trial Report

Please provide your email address so we can email your sample rescue trial report.